Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation

Molecular and Cellular Biology

Volumn 32, Issue 7, 2012, Pages 1237-1247

  Berlin, Irina ^a,b   Denat, Laurence ^a,b   Steunou, Anne Lise ^c   Puig, Isabel ^a,b   Champeval, Delphine ^a,b   Colombo, Sophie ^a,b   Roberts, Karen ^d   Bonvin, Elise ^a,b,d   Bourgeois, Yveline ^a,b   Davidson, Irwin ^e   Delmas, Véronique ^a,b   Nieto, Laurence ^c   Goding, Colin R ^d   Larue, Lionel ^a,b  

^a INSTITUT CURIE   (France)

^b Centre National de la Recherche Scientifique   (France)

^c INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; BRN2 PROTEIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX3; UNCLASSIFIED DRUG; MITF PROTEIN, MOUSE; NERVE PROTEIN; PAIRED BOX TRANSCRIPTION FACTOR; PAX3 PROTEIN, MOUSE; POU3F2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR POU;

ANIMAL CELL; ARTICLE; CELL LINEAGE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; MELANOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; ANIMAL; CELL MOTION; CYTOLOGY; GENETIC TRANSCRIPTION; GENETICS; HUMAN; MELANOMA; METABOLISM; MUTATION; PHOSPHORYLATION; PROMOTER REGION; TRANSGENIC MOUSE; TUMOR CELL LINE;

MUS MUSCULUS;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; MELANOCYTES; MELANOMA; MICE; MICE, TRANSGENIC; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MUTATION; NERVE TISSUE PROTEINS; PAIRED BOX TRANSCRIPTION FACTORS; PHENOTYPE; PHOSPHORYLATION; POU DOMAIN FACTORS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

EID: 84859962777     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.06257-11     Document Type: Article

References (64)

1. Abdel-Malek ZA, et al. 2001. The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes. J. Cell Sci. 114:1019-1024.
2. Alazard R, et al. 2005. Identification of the 'NORE' (N-Oct-3 responsive element), a novel structural motif and composite element. Nucleic Acids Res. 33:1513-1523.
3. Andersen B, Rosenfeld MG. 2001. POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human disease. Endocr. Rev. 22:2-35.
4. Arozarena I, et al. 2011. Oncogenic BRAF Induces Melanoma Cell Invasion by Downregulating the cGMP-Specific Phosphodiesterase PDE5A. Cancer Cell 19:45-57.
5. Augustijn KD, et al. 2002. Structural characterization of the PIT-1/ETS-1 interaction: PIT-1 phosphorylation regulates PIT-1/ETS-1 binding. Proc. Natl. Acad. Sci. U. S. A. 99:12657-12662.
6. Barr FG, et al. 1999. Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell lines. Cancer Res. 59: 5443-5448.
7. Bennett DC, et al. 1989. Cloned mouse melanocyte lines carrying the germline mutations albino and brown: complementation in culture. Development 105:379-385.
8. Berlin I, et al. 2012. General strategy to analyse coat colour phenotypes in mice. Pigment Cell Melanoma Res. 25:117-119.
9. Blake JA, Ziman MR. 2005. Pax3 transcripts in melanoblast development. Dev. Growth Differ. 47:627-635.
10. Boyle GM, et al. 2011. Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor. Pigment Cell Melanoma Res. 24:525-537.
11. Cabos-Siguier B, et al. 2009. Expression and purification of human fulllengthNOct-3, a transcription factor involved in melanoma growth. Protein Expr. Purif. 64:39-46.
12. Carreira S, et al. 2005. Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression. Nature 433:764-769.
13. Carreira S, et al. 2006. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev. 20:3426-3439.
14. Castro DS, et al. 2006. Proneural bHLH and Brn proteins coregulate a neurogenic program through cooperative binding to a conserved DNA motif. Dev. Cell 11:831-844.
15. Colombo S, Champeval D, Rambow F, Larue L. 2012. Transcriptomic analysis of mouse embryonic skin cells reveals previously unreported genes expressed in melanoblasts. J. Invest. Dermatol. 132:170-178.
16. Colombo S, Kumasaka M, Lobe C, Larue L. 2010. Genomic localization of the Z/EG transgene in the mouse genome. Genesis 48:96-100.
17. Cook AL, Sturm RA. 2008. POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis. Pigment Cell Melanoma Res. 21:611-626.
18. Delmas V, et al. 2007. Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes Dev. 21:2923-2935.
19. Delmas V, Martinozzi S, Bourgeois Y, Holzenberger M, Larue L. 2003. Cre-mediated recombination in the skin melanocyte lineage. Genesis 36:73-80.
20. Diamond SE, Chiono M, Gutierrez-Hartmann A. 1999. Reconstitution of the protein kinase A response of the rat prolactin promoter: differential effects of distinct Pit-1 isoforms and functional interaction with Oct-1. Mol. Endocrinol. 13:228-238.
21. French AD, et al. 2009. PKC and PKA phosphorylation affect the subcellular localization of claudin-1 in melanoma cells. Int. J. Med. Sci. 6:93-101.
22. Gallagher SJ, et al. 2011. General strategy to analyse melanoma in mice. Pigment Cell Melanoma Res. 24:987-988.
23. Goodall J, et al. 2008. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells. Cancer Res. 68:7788-7794.
24. Goodall J, et al. 2004. Brn-2 expression controls melanoma proliferation and is directly regulated by beta-catenin. Mol. Cell. Biol. 24:2915-2922.
25. Goodall J, et al. 2004. The Brn-2 transcription factor links activated BRAF to melanoma proliferation. Mol. Cell. Biol. 24:2923-2931.
26. Hagino-Yamagishi K, et al. 1997. Predominant expression of Brn-2 in the postmitotic neurons of the developing mouse neocortex. Brain Res. 752: 261-268.
27. Hanke T, Szawlowski P, Randall RE. 1992. Construction of solid matrixantibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen. J. Gen. Virol. 73(Pt. 3):653-660.
28. Hara Y, Rovescalli AC, Kim Y, Nirenberg M. 1992. Structure and evolution of four POU domain genes expressed in mouse brain. Proc. Natl. Acad. Sci. U. S. A. 89:3280-3284.
29. Hirobe T, Abe H. 1999. Genetic and epigenetic control of the proliferation and differentiation of mouse epidermal melanocytes in culture. Pigment Cell Res. 12:147-163.
30. Hodgkinson CA, et al. 1993. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helixloop-helix-zipper protein. Cell 74:395-404.
31. Kapiloff MS, Farkash Y, Wegner M, Rosenfeld MG. 1991. Variable effects of phosphorylation of Pit-1 dictated by the DNA response elements. Science 253:786-789.
32. Kasibhatla S, et al. 1999. Jun kinase phosphorylates and regulates the DNA binding activity of an octamer binding protein, T-cell factor beta1. Mol. Cell. Biol. 19:2021-2031.
33. Kobi D, et al. 2010. Genome-wide analysis of POU3F2/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene. Pigment Cell Melanoma Res. 23:404-418.
34. Kubic JD, Young KP, Plummer RS, Ludvik AE, Lang D. 2008. Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease. Pigment Cell Melanoma Res. 21:627-645.
35. Larue L, Dougherty N, Porter S, Mintz B. 1992. Spontaneous malignant transformation of melanocytes explanted from Wf/Wf mice with a Kit kinase-domain mutation. Proc. Natl. Acad. Sci. U. S. A. 89:7816-7820.
36. Lee M, Goodall J, Verastegui C, Ballotti R, Goding CR. 2000. Direct regulation of the Microphthalmia promoter by Sox10 links Waardenburg-Shah syndrome (WS4)-associated hypopigmentation and deafness to WS2. J. Biol. Chem. 275:37978-37983.
37. Lefort K, Rouault JP, Tondereau L, Magaud JP, Dore JF. 2001. The specific activation of gadd45 following UVB radiation requires the POU family gene product N-oct3 in human melanoma cells. Oncogene 20: 7375-7385.
38. Luciani F, et al. 2011. Biological and mathematical modeling of melanocyte development. Development 138:3943-3954.
39. Mackenzie MA, Jordan SA, Budd PS, Jackson IJ. 1997. Activation of the receptor tyrosine kinase Kit is required for the proliferation of melanoblasts in the mouse embryo. Dev. Biol. 192:99-107.
40. Medic S, Rizos H, Ziman M. 2011. Differential PAX3 functions in normal skin melanocytes and melanoma cells. Biochem. Biophys. Res. Commun. 411:832-837.
41. Milewski RC, et al. 2004. Identification of minimal enhancer elements sufficient for Pax3 expression in neural crest and implication of Tead2 as a regulator of Pax3. Development 131:829-837.
42. Moore R, et al. 2004. Involvement of cadherins 7 and 20 in mouse embryogenesis and melanocyte transformation. Oncogene 23:6726-6735.
43. Moriyama M, et al. 2006. Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocyte stem cells. J. Cell Biol. 173:333-339.
44. Nakai S, et al. 1995. The POU domain transcription factor Brn-2 is required for the determination of specific neuronal lineages in the hypothalamus of the mouse. Genes Dev. 9:3109-3121.
45. Nakatani Y, Ogryzko V. 2003. Immunoaffinity purification of mammalian protein complexes. Methods Enzymol. 370:430-444.
46. Nieto L, et al. 2007. Differential effects of phosphorylation on DNA binding properties of N Oct-3 are dictated by protein/DNA complex structures. J. Mol. Biol. 370:687-700.
47. Novak A, Guo C, Yang W, Nagy A, Lobe CG. 2000. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis 28:147-155.
48. Pinner S, et al. 2009. Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination. Cancer Res. 69:7969-7977.
49. Relaix F, et al. 2003. The transcriptional activator PAX3-FKHR rescues the defects of Pax3 mutant mice but induces a myogenic gain-of-function phenotype with ligand-independent activation of Met signaling in vivo. Genes Dev. 17:2950-2965.
50. Reményi A, et al. 2001. Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. Mol. Cell 8:569-580.
51. Scholl FA, et al. 2001. PAX3 is expressed in human melanomas and contributes to tumor cell survival. Cancer Res. 61:823-826.
52. Schonemann MD, et al. 1995. Development and survival of the endocrine hypothalamus and posterior pituitary gland requires the neuronal POU domain factor Brn-2. Genes Dev. 9:3122-3135.
53. Schouwey K, et al. 2007. Notch1 and Notch2 receptors influence progressive hair graying in a dose-dependent manner. Dev. Dyn. 236:282-289.
54. Schwahn DJ, Xu W, Herrin AB, Bales ES, Medrano EE. 2001. Tyrosine levels regulate the melanogenic response to alpha-melanocyte-stimulating hormone in human melanocytes: implications for pigmentation and proliferation. Pigment Cell Res. 14:32-39.
55. Segil N, Roberts SB, Heintz N. 1991. Mitotic phosphorylation of the Oct-1 homeodomain and regulation of Oct-1 DNA binding activity. Science 254:1814-1816.
56. Strub T, et al. 2011. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene 30:2319-2332.
57. Swope VB, Medrano EE, Smalara D, Abdel-Malek ZA. 1995. Long-term proliferation of human melanocytes is supported by the physiologic mitogens alpha-melanotropin, endothelin-1, and basic fibroblast growth factor. Exp. Cell Res. 217:453-459.
58. Tamura A, et al. 1987. Normal murine melanocytes in culture. In Vitro Cell Dev. Biol. 23:519-522.
59. Thomson JA, et al. 1995. The Brn-2 gene regulates the melanocytic phenotype and tumorigenic potential of human melanoma cells. Oncogene 11:691-700.
60. Thurber AE, et al. 2011. Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway. Oncogene 30:3036-3048.
61. Vierbuchen T, et al. 2010. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463:1035-1041.
62. Wang Q, Kumar S, Slevin M, Kumar P. 2006. Functional Analysis of Alternative Isoforms of the Transcription Factor PAX3 in Melanocytes In vitro. Cancer Res. 66:8574-8580.
63. Wellbrock C, et al. 2008. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. PLoS One 3:e2734.
64. Zhu BK, Pruitt SC. 2005. Determination of transcription factors and their possible roles in the regulation of Pax3 gene expression in the mouse B16 F1 melanoma cell line. Melanoma Res. 15:363-373.